Clinical Trial Update: A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma

View source ↗

Summary

A Phase III trial for post-operative HBV-related hepatocellular carcinoma was terminated; no efficacy results are reported in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Hepatocellular Carcinoma | Status: TERMINATED